Get started
Author

Sarah Lomahan

Observed names: Lomahan, Sarah, SARAH LOMAHAN
ORCID: 0000-0002-4728-2709
Observed ORCID: 0000-0002-4728-2709
OpenAlex ID: A5005288859
Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin
2013 · STEPHANIE S. WANG, RUTH HSIAO, et al. · International Journal of Molecular Medicine · 20
PDF
Aurora kinase A is a possible target of OSU-03012 to destabilize MYC family proteins
2014 · ANDRES SILVA, JENNIE WANG, et al. · Oncology Reports · 14
PDF
What Chicago community organizations needed to implement COVID-19 interventions: lessons learned in 2021
2023 · David A. Moskowitz, Abigail Silva, et al. · Frontiers in Public Health · 6
PDF
Trust and Trustworthiness: Considerations for COVID-19 Vaccine Receipt in the Chicago Metropolitan Area
2024 · Jessica Bishop-Royse, Melissa Gutierrez-Kapheim, et al. · Journal of Community Health · 4
Community-Based Organizations Leading Research Efforts: Preliminary Findings from the Chicagoland CEAL Program’s COVID-19 Vaccine Uptake and Intention Survey
2024 · Paris Thomas, Jessica Bishop-Royse, et al. · Journal of Racial and Ethnic Health Disparities · 4
The role of facility and patient mix factors on recovery of screening and diagnostic mammography volumes following the initial COVID ‐19 pandemic wave
2023 · Sarah Lomahan, Garth H. Rauscher, et al. · Cancer Medicine · 2
PDF
Trends in utilization of cervical cancer screening and screening-associated services in a multi-organizational research network in Chicago, Illinois, US
2026 · Hunter K. Holt, Weiwei Ma, et al. · Gynecologic Oncology
PDF
Abstract C172: Evaluating interest in the EPIC (Equitable, Patient-centered, and Innovative Care) Medicaid breast cancer quality improvement initiative for Chicago women
2026 · Sarah Boglione, Zoe Parrott, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract C171: Assessing appointment completion in the EPIC (Equitable, Patient-centered, and Innovative Care) Medicaid breast cancer quality improvement initiative for Chicago women
2026 · Zoe Parrott, Sarah Boglione, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract B169: Association between social determinants of health and compliance with recommended breast, cervical, and colorectal cancer screenings
2026 · Emily Kidd, Grace Kadubek, et al. · Cancer Epidemiology Biomarkers & Prevention
Using facility zip code level mammography utilization to overcome biases that plague survey data on screening utilization
2026 · Garth Rauscher*, Sarah Lomahan, et al. · Epidemiology
Correction: Trust and Trustworthiness: Considerations for COVID-19 Vaccine Receipt in the Chicago Metropolitan Area
2026 · Jessica Bishop-Royse, Melissa Gutierrez-Kapheim, et al. · Journal of Community Health
PDF
Equal Hope's Medicaid breast cancer coordination of care improvement initiative.
2026 · Sarah Lomahan, Jiana Calixto, et al. · Journal of Clinical Oncology
Abstract B028: Navigating change: Equal Hope’s response to Chicago’s Latine community needs
2025 · Gabriela A. Pena, Grace Kadubek, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract C147: Cervical cancer screening adherence on Chicago’s West and South sides
2025 · Grace Kadubek, Gabriela Pena, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract B029: Photovoice: Through her eyes
2025 · Gabriela A. Pena, Grace Kadubek, et al. · Cancer Epidemiology Biomarkers & Prevention
Beliefs related to COVID-19 vaccine receipt in the Chicago area
2025 · Sarah Lomahan, Abigail Silva, et al. · Discover Public Health
PDF
Corrigendum: What Chicago community organizations needed to implement COVID-19 interventions: lessons learned in 2021
2025 · David A. Moskowitz, Abigail Silva, et al. · Frontiers in Public Health
PDF
Assessing capacity for hereditary cancer risk assessment in metro Chicago.
2024 · Tamara Hamlish, Vivian Pan, et al. · JCO Oncology Practice
Abstract 4215: Small molecule compounds that destabilize stem cell factors
2015 · Naohiko Ikegaki, Sarah Lomahan, et al. · Cancer Research
Abstract 3910: Identification of lead organic compounds active against stem cell-like neuroblastoma cells by high throughput screening
2014 · Naohiko Ikegaki, Kiira Ratia, et al. · Cancer Research
Abstract 3858: Implications of the downregulation of stemness/reprogramming factor expression by ibuprofen and biguanides
2014 · Laura Grenlin, Tuan-Anh Tran, et al. · Cancer Research
Works count: 23
Citation count: 50
H-index: 4
I10-index: 2
Year
Topic
Type